Stock Events

Stock Events

Co-Diagnostics 

0
116
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q1 2026
Next
-3.48
-3.2
-2.91
-2.63
Expected EPS
-2.62806
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow C97.STU. It's not an investment recommendation.
Tesla
22
TSLA
Apple
21
AAPL
Microsoft
21
MSFT
Amazon
21
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap8.07B
QIAGEN offers diagnostic solutions, including molecular diagnostics which directly compete with Co-Diagnostics' testing technologies.
Thermo Fisher Scientific
TMO
Mkt Cap194.52B
Thermo Fisher Scientific provides a broad range of diagnostic and research products, including molecular diagnostics that compete with CODX offerings.
Bio-Rad Laboratories
BIO
Mkt Cap7.94B
Bio-Rad Laboratories offers a variety of diagnostic tests and systems, including PCR-based tests, which are in direct competition with Co-Diagnostics' products.
Quest Diagnostics
DGX
Mkt Cap23.88B
Quest Diagnostics provides diagnostic testing services, including molecular diagnostics, competing with Co-Diagnostics in the laboratory testing market.
Labcorp
LH
Mkt Cap23.53B
Laboratory Corporation of America offers a wide range of diagnostic tests, including molecular diagnostics, making it a competitor in the diagnostics market.
Abbott Laboratories
ABT
Mkt Cap166.17B
Abbott Laboratories offers a broad portfolio of diagnostic products, including molecular diagnostics, competing across several of Co-Diagnostics' market segments.
Agilent Technologies
A
Mkt Cap36.91B
Agilent Technologies provides life sciences, diagnostics, and applied chemical markets with instruments and services, including diagnostics that compete with Co-Diagnostics.
Baxter International
BAX
Mkt Cap11.7B
Baxter International offers a range of medical devices and laboratory equipment, some of which are used in diagnostic applications that compete with Co-Diagnostics.
Roche
RHHBY
Mkt Cap341.62B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including molecular diagnostics, making it a significant competitor to Co-Diagnostics in the global diagnostics market.

About

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Show more...
CEO
Mr. Dwight H. Egan
Employees
115
Country
United States
ISIN
US1897631057

Listings

STU
DE
C970.STU
STU
DE
C97.STU
MU
DE
C970.MU
LSE
GB
0A50.LSE

0 Comments

Share your thoughts

FAQ

What is Co-Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Co-Diagnostics stocks are traded under the ticker C97.STU.
When is the next Co-Diagnostics earnings date?▼
Co-Diagnostics is going to release the next earnings report on August 06, 2026.
What were Co-Diagnostics earnings last quarter?▼
C97.STU earnings for the last quarter are -3.48 EUR per share, whereas the estimation was -3.21 EUR resulting in a -8.27% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Co-Diagnostics have?▼
As of July 11, 2026, the company has 115 employees.
In which sector is Co-Diagnostics located?▼
Co-Diagnostics operates in the Other sector.
When did Co-Diagnostics complete a stock split?▼
Co-Diagnostics has not had any recent stock splits.
Where is Co-Diagnostics headquartered?▼
Co-Diagnostics is headquartered in Salt Lake City, United States.